Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Atara Biotherapeutics, Inc. (ATRA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17
   10-K8-K10-K8-K10-K10-K10-K10-K
Revenues  31.0272.50.0282.00.00.00.00.0
            Revenue growth   -3.4%      
Cost of goods sold  0.0209.00.0360.80.00.00.00.0
Gross profit  31.063.60.0-78.80.00.00.00.0
            Gross margin  100.0%23.3% -27.9%    
Selling, general and administrative   [+]344.171.6360.878.8309.179.669.740.3
Research and development       216.1167.581.2
Other operating expenses  -50.2322.8-360.8182.9-309.1   
EBITDA   [+]-257.2 9.3 8.3-288.6-233.4-120.6
            EBITDA margin  -829.8%-121.4% -120.7%    
Depreciation and amortization  5.7 9.3 8.37.13.71.0
EBIT   [+]-262.9-330.80.0-340.50.0-295.7-237.1-121.5
            EBIT margin  -848.0%-121.4% -120.7%    
Non-recurring items   [+]50.2-50.2      
Other income (expense), net   [+]84.852.2-340.10.4-306.64.76.42.0
Pre-tax income  -228.3-228.3-340.1-340.1-306.6-291.0-230.7-119.5
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate        0.0%0.0%
Net income  -228.3-228.3-340.1-340.1-306.6-291.0-230.7-119.5
            Net margin  -736.5%-83.8% -120.6%    
   
Basic EPS   [+]($2.24)($2.24)($3.63)($3.63)($4.15)($5.67)($5.27)($4.00)
Diluted EPS   [+]($2.24)($2.24)($3.63)($3.63)($4.15)($5.67)($5.27)($4.00)
   
Shares outstanding (basic)   [+]102.0102.093.793.774.051.343.829.9
Shares outstanding (diluted)   [+]102.0102.093.793.774.051.343.829.9
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy